A woman is suing Frito-Lay, the snack division of PepsiCo, for what she says is deceptive use of the phrase “all natural ingredients” on its packages of products like Tostitos […]
Bicycle and car parts retailer Halfords Plc announced the appointment of Jill McDonald as CEO, replacing Matt Davies who is leaving to take the chief executive post at Tesco. McDonald joins from McDonald’s Corporation (no relation), where she started as chief marketing officer in 2006 and rose to the position of CEO of the company’s UK division and president of its North West Europe division, a role she held since 2010. Prior to her career at the restaurant giant, McDonald held brand management and marketing positions with Colgate-Palmolive and British Airways.
March 16, 2015
In an update last week, Dun & Bradstreet editor Adam Anderson detailed how Southwest Airlines‘ simple approach (low cost, no frills) — combined with a steep decline in fuel and oil prices — led to milestone revenue and net income in 2014. It reported revenue of $18.6 billion last year, with net income of $1.1 billion. A key to future growth for the airline is international service; in 2014 the company launched service to Jamaica, Aruba, and the Bahamas, with plans this year for service to Costa Rica and Belize, among other destinations. Follow Adam on Twitter.
March 23, 2015
FDA approval of the first copycat version of a biotech drug opens the gates on a new market that could help some drug manufacturers but hurt others. Pharmaceutical companies have invested heavily in development of patent-protected biologic drugs, which are produced through manipulation of living cells (as opposed to chemical substances). Though several copycat biotech drugs, known as biosimilars, are sold in Europe and other regions, Novartis’ Zarxio for treatment of chemotherapy-related infections (a generic version of Amgen’s Neupogen) is the first biosimilar approved for sale in the US, after much debate. For more industry trends, please see our Pharmaceutical Manufacturing profile.